Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Clinical Pharmacology and Therapeutics
|
April 17, 2013
The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics
O Gottesman, S A Scott, S B Ellis, et al.
Scientific Reports
|
November 9, 2016
Capturing Structural Dynamics in Crystalline Silicon Using Chirped Electrons from a Laser Wakefield Accelerator
Z-H He, B Beaurepaire, J A Nees, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update
S A Scott, K Sangkuhl, C M Stein, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2010
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population
S A Lubitz, S A Scott, E B Rothlauf, et al.
Oncogene
|
August 6, 2013
Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
R Cipriano, B L Bryson, K L S Miskimen, et al.
Cell Death and Differentiation
|
January 8, 2011
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells
O Cordero-Llana, S A Scott, S L Maslen, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2016
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy
B Moriyama, A Owusu Obeng, J Barbarino, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity
S A Scott, J-P Collet, U Baber, et al.
Clinical Pharmacology and Therapeutics
|
September 9, 2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
J A Johnson, L Gong, M Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
October 29, 2010
Correlation between imatinib pharmacokinetics and clinical response in Japanese patients with chronic-phase chronic myeloid leukemia
N Takahashi, H Wakita, M Miura, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Clinical Pharmacology and Therapeutics
|
April 17, 2013
The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics
O Gottesman, S A Scott, S B Ellis, et al.
Scientific Reports
|
November 9, 2016
Capturing Structural Dynamics in Crystalline Silicon Using Chirped Electrons from a Laser Wakefield Accelerator
Z-H He, B Beaurepaire, J A Nees, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update
S A Scott, K Sangkuhl, C M Stein, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 5, 2010
Comparative performance of gene-based warfarin dosing algorithms in a multiethnic population
S A Lubitz, S A Scott, E B Rothlauf, et al.
Oncogene
|
August 6, 2013
Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B
R Cipriano, B L Bryson, K L S Miskimen, et al.
Cell Death and Differentiation
|
January 8, 2011
Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells
O Cordero-Llana, S A Scott, S L Maslen, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2016
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy
B Moriyama, A Owusu Obeng, J Barbarino, et al.
Clinical Pharmacology and Therapeutics
|
May 24, 2016
Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity
S A Scott, J-P Collet, U Baber, et al.
Clinical Pharmacology and Therapeutics
|
September 9, 2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing
J A Johnson, L Gong, M Whirl-Carrillo, et al.
Clinical Pharmacology and Therapeutics
|
October 29, 2010
Correlation between imatinib pharmacokinetics and clinical response in Japanese patients with chronic-phase chronic myeloid leukemia
N Takahashi, H Wakita, M Miura, et al.
Page
of 10